While CSF1R inhibition is a well accepted approach to assess the role of microglia in neurodegenerative diseases [17], potential side-effects must be considered, as well as potential contributing roles of perivascular and meningeal macrophages, which are also eliminated. This evidence concerns the gene CSF1R and neurodegenerative disease.